|Bid||8.50 x 1400|
|Ask||13.86 x 1000|
|Day's Range||9.60 - 10.99|
|52 Week Range||8.75 - 24.67|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.00|
SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference. From November 22nd to December 2nd, presentations will be available for registered attendees via the Piper Sandler conference site. Exagen will be participating in one-on-one meetings on December 1st. Meetings can be requested exclusively via Piper Sandler. Ron Rocca, Exagen’s
Earlier today, Exagen Inc. released financial results for the quarter ended September 30, 2021. Ron Rocca, president and chief executive officer; Kamal Adawi, chief financial officer; and Mark Hazeltine, chief operating officer, will host this afternoon's call.
Exagen Inc. (XGN) delivered earnings and revenue surprises of 2.33% and 0.97%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?